Melanie Olesky, Ph.D.
Affiliations: | 2002 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Pharmacology, Cell BiologyGoogle:
"Melanie Olesky"Mean distance: 23748
Parents
Sign in to add mentor| Robert A. Nicholas | grad student | 2002 | UNC Chapel Hill | |
| (The mechanism of porin -mediated antibiotic resistance in Neisseria gonorrhoeae.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Morrissey I, Olesky M, Hawser S, et al. (2019) Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017. Antimicrobial Agents and Chemotherapy |
| Seifert H, Stefanik D, Olesky M, et al. (2019) In-vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii. International Journal of Antimicrobial Agents |
| Solomkin JS, Sway A, Lawrence K, et al. (2019) Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance. Future Microbiology |
| Gupta V, Ye G, Olesky M, et al. (2019) Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017. Bmc Infectious Diseases. 19: 742 |
| Gupta V, Ye G, Olesky M, et al. (2019) National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases |
| Lodise T, Izmailyan S, Olesky M, et al. (2019) 2264. An Evaluation of Empiric Treatment Patterns for Adult Patients with Community-Onset (CO) “Low-Risk” (LR) Complicated Intra-Abdominal Infections (cIAI) Across US Hospitals Open Forum Infectious Diseases. 6: S775-S775 |
| Zilberberg M, Nathanson B, Lawrence K, et al. (2019) 2259. Predictors of Empiric Carbapenem Therapy in Complicated Intra-Abdominal Infections in the United States, 2013–2017: A Retrospective Cohort Study Open Forum Infectious Diseases. 6: S773-S773 |
| Tabak Y, Olesky M, Efimova E, et al. (2018) 611: Multidrug-Resistant Enterobacteriaceae Infections By Pathogen And Icu Type Critical Care Medicine. 46: 292 |
| Olesky M, Johannes R, Ye G, et al. (2017) Trends in Resistant Enterobacteriaceae (ENT), Acinetobacter baumannii (ACB) and Extended Spectrum Beta-Lactamase (ESBL) Organisms in Hospitalized Patients in the US: 2011-2016 Open Forum Infectious Diseases. 4 |
| Hoffman-Roberts H, Olesky M, Tabak YP, et al. (2016) National Prevalence of Carbapenem-Resistant Enterobacteriaceae in the Ambulatory and Acute Care Settings in the United States in 2015 Open Forum Infectious Diseases. 3 |